TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Highlights of Dingell Hearing: Statements Of Visco, Testimony By Broder On Fisher, Uterine Cancer Deaths April 22, 1994
TCL Archive Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses June 13, 1986
TCL Archive FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach. February 6, 2004
